Abstract

Abstract In addition to the long standing efforts to understand and manipulate the immune system in the treatment of autoimmune diseases, the immune system is increasingly becoming a direct target for cancer therapeutics. Recent advances in flow and mass cytometry have greatly expanded the number of immune cell parameters that can be interrogated resulting in an improved understanding of the immune system heterogeneity. These technologies, however, remain limited in the number and types of analytes that can be examined in a single clinical sample. The NanoString nCounter® platform enables the highly multiplexed digital analysis of both RNA and protein from a single biological specimen for multiple research applications. We have recently developed the nCounter® Vantage 3D™ RNA:Protein Immune Cell Profiling Assay for research applications, which interrogates 30 cell surface proteins and 770 immune-related RNAs starting with cells in suspension. Expanding on this, we demonstrate the development of a streamlined workflow that integrates standard immune cell sorting with downstream nCounter® analysis. By co-staining PBMCs with both fluorescently-labeled and DNA barcoded antibodies, CD8+ and CD4+ T cells and CD19+ B cells were isolated followed by analysis of dozens of additional proteins and 770 RNA from each sorted population. Demonstrating the value of this workflow in analyzing potentially rare cell populations, the number of target cells were titrated to determine the sensitivity of the workflow. Without the requirement for additional molecular biology methods, such as RNA purification or sequencing library construction, this method is ideally suited for incorporation into any cell sorting workflow.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call